Ignite Creation Date:
2025-12-24 @ 10:51 PM
Ignite Modification Date:
2026-01-05 @ 5:36 PM
Study NCT ID:
NCT01955369
Status:
COMPLETED
Last Update Posted:
2016-05-19
First Post:
2013-09-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Amyotrophic Lateral Sclerosis Registry Rhineland-Palatinate
Sponsor:
Klinikum Ludwigshafen
Organization:
Study Overview
Official Title:
Amyotrophic Lateral Sclerosis Registry Rhineland-Palatinate
Status:
COMPLETED
Status Verified Date:
2016-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
There is a lack of prospective and population-based epidemiological data on amyotrophic lateral sclerosis in Germany so far. The purpose of this registry is to investigate the incidence, course and phenotypic variety of ALS in Rhineland-Palatinate, a South-West German state of about 4 million inhabitants.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: